MDT

100.26

+3%↑

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

Home・Aktien・Pulmatrix Inc

Pulmatrix Inc

Geschlossen

2.23 -0.45

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.2

Max

2.3

Schlüsselkennzahlen
By Trading Economics
Einkommen	672K -877K
EPS	-0.24
Gewinnspanne	-60,266.667
Angestellte	2
EBITDA	671K -877K

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-9.8M 8.1M
Vorheriger Eröffnungskurs	2.68
Vorheriger Schlusskurs	2.23

Pulmatrix Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

6. Jan. 2026, 21:14 UTC

Wichtige Markttreiber

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6. Jan. 2026, 19:23 UTC

Akquisitionen, Fusionen, Übernahmen

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6. Jan. 2026, 17:41 UTC

Wichtige Markttreiber

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6. Jan. 2026, 15:46 UTC

Akquisitionen, Fusionen, Übernahmen

Advent International Leads InPost Takeover Offer, Sky News Says

6. Jan. 2026, 15:37 UTC

Wichtige Markttreiber

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6. Jan. 2026, 23:46 UTC

Market Talk

Nikkei May Decline After Hitting Record High -- Market Talk

6. Jan. 2026, 23:35 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6. Jan. 2026, 23:19 UTC

Market Talk

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6. Jan. 2026, 22:53 UTC

Market Talk

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6. Jan. 2026, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6. Jan. 2026, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. Jan. 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. Jan. 2026, 21:12 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

6. Jan. 2026, 21:12 UTC

Market Talk

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6. Jan. 2026, 20:59 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Deal Could Be Announced Imminently, Sources Say -- WSJ

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6. Jan. 2026, 20:01 UTC

Market Talk

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6. Jan. 2026, 19:52 UTC

Market Talk

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6. Jan. 2026, 19:46 UTC

Akquisitionen, Fusionen, Übernahmen

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6. Jan. 2026, 19:08 UTC

Akquisitionen, Fusionen, Übernahmen

OneStream to Go Private Through $6.4B Hg Acquisition

6. Jan. 2026, 18:28 UTC

Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6. Jan. 2026, 17:20 UTC

Market Talk

Ergebnisse

Financial Services Roundup: Market Talk

6. Jan. 2026, 17:20 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

6. Jan. 2026, 15:57 UTC

Market Talk

Crude Futures Ease Back From Early Gains -- Market Talk

6. Jan. 2026, 15:34 UTC

Market Talk

Ergebnisse

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6. Jan. 2026, 15:27 UTC

Market Talk

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Peer-Vergleich

Kursveränderung

Pulmatrix Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pulmatrix Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.